ALK and non-small cell lung carcinoma: As opposed to the classic oncogenic drivers in naïve NSCLC tumors, they frequently harbor uncommon 5’ partners, such as NCOA4 for RET fusion or CCDC6 for ALK fusions, with unusual breakpoints.